On Wednesday, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’s shares declined -0.21% to $47.60.
ACADIA Pharmaceuticals Inc. (ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, recently declared the following senior administration appointments:
- James A. Nash, Senior Vice President, Technology Development and Operations
- Ryan E. Brown, Vice President, Chief Compliance Officer
- Fred W. Manak, Jr., Vice President, Access and Reimbursement
- BobMischler, Vice President, Strategy and Business Development
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which accomplished the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis; is in Phase II study for Alzheimer’s disease psychosis; and has accomplished Phase II trial for the treatment of schizophrenia.
Weingarten Realty Investors (NYSE:WRI)’s shares dropped -0.77% to $34.84.
Weingarten Realty (WRI) declared the results of its operations for the quarter ended June 30, 2015. The supplemental financial package with additional information can be found on the Company’s website under the Investor Relations tab.
Second Quarter Operating and Financial Highlights
- Recurring Funds from Operations Attributable to Common Shareholders (“FFO”) for the quarter raised to $0.54 per diluted share from $0.51 per diluted share a year ago;
- Same Property Net Operating Income raised 4.1% over the same quarter of the preceding year;
- Occupancy raised 0.7% over the same quarter of the preceding year to 95.5%;
- Rental rates on new leases and renewals were up 16.8% and 10.9%, respectively;
- Senior unsecured bonds totaling $250 million were issued at an all-in cost of 3.77%; and
- Acquisitions totaling $81 million were accomplished during the quarter.
Weingarten Realty Investors is a publically owned equity real estate investment trust. The firm invests in the real estate markets of United States. The firm engages in ownership, administration, acquisition, development and redevelopment. It makes its investments in neighborhood and community shopping centers. Weingarten Realty Investors was formed in 1948, and is based in Houston, Texas.
At the end of Wednesday’s trade, Fairway Group Holdings Corp (NASDAQ:FWM)‘s shares dipped -21.33% to $2.36.
Fairway Group Holdings Corp. (FWM), the parent company of Fairway Market, recently declared financial results for its fiscal 2016 first quarter ended June 28, 2015.
First Quarter Fiscal 2016 Highlights
- Net sales of $193.8 million
- Adjusted EBITDA of $9.1 million
- Gross margin of 31.5%
Operating Results for the First Quarter of Fiscal 2016
Net sales were $193.8 million for the first quarter of fiscal 2016 contrast to $198.3 million for the first quarter of fiscal 2015. During the quarter, we invested about $2.8 million, or 1.4% of sales, for raised promotional activity, in large part related to the continued development of our digital customer engagement strategy, reducing sales by this amount. Same store sales reduced 5.3% for the first quarter of fiscal 2016 contrast to the first quarter of fiscal 2015. Customer transactions in our comparable stores reduced by 7.4%, although the average transaction size raised by 2.3% contrast to the first quarter of last year. Same store sales were negatively influenced by about 170 basis points due to a recent competitive opening near our Upper Eastside location and about 130 basis points due to raised promotional activity. Not taking into account the impact of the Upper Eastside location and the raised promotional activity, same store sales reduced about 2.3%.
Fairway Group Holdings Corp., together with its auxiliaries, operates as a food retailer in the United States. The company offers fresh produce; Deli products, such as sandwiches, side dishes, toppings, platters, snacks, and main dishes; specialty and gourmet products; cheese; meat and chicken products; seafood products; bakery products comprising cookies, tarts, cupcakes, baguettes, and bagels; coffee; and kosher products.
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS), ended its Wednesday’s trading session with -5.00% loss, and closed at $1.33.
Sunesis Pharmaceuticals, Inc. (SNSS) declared that Daniel Swisher, Chief Executive Officer of Sunesis, will present at the 2015 Wedbush PacGrow Healthcare Conference on Wednesday, August 12th at 10:20 AM Eastern Time at Le Parker Meridien Hotel in New York City.
Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company is developing vosaroxin, an anti-cancer quinolone derivative for the treatment of acute myeloid leukemia (AML). It has accomplished a Phase III, randomized, double-blind, and placebo-controlled trial of vosaroxin in combination with cytarabine in patients with relapsed or refractory AML.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
